Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 7 May 1999:
Vol. 284. no. 5416, pp. 974 - 977
DOI: 10.1126/science.284.5416.974
Prev | Table of Contents | Next

Reports

Discovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in Mice

Bei Zhang, 1* Gino Salituro, 2 Deborah Szalkowski, 1 Zhihua Li, 1 Yan Zhang, 2 Inmaculada Royo, 4 Dolores Vilella, 4 Maria Teresa Díez, 4 Fernando Pelaez, 4 Caroline Ruby, 2 Richard L. Kendall, 5 Xianzhi Mao, 5 Patrick Griffin, 3 Jimmy Calaycay, 3 Juleen R. Zierath, 6 James V. Heck, 2 Roy G. Smith, 1dagger David E. Moller 1

Insulin elicits a spectrum of biological responses by binding to its cell surface receptor. In a screen for small molecules that activate the human insulin receptor tyrosine kinase, a nonpeptidyl fungal metabolite (L-783,281) was identified that acted as an insulin mimetic in several biochemical and cellular assays. The compound was selective for insulin receptor versus insulin-like growth factor I (IGFI) receptor and other receptor tyrosine kinases. Oral administration of L-783,281 to two mouse models of diabetes resulted in significant lowering in blood glucose levels. These results demonstrate the feasibility of discovering novel insulin receptor activators that may lead to new therapies for diabetes.

1 Department of Molecular Endocrinology,
2 Department of Natural Product Drug Discovery,
3 Department of Molecular Diversity and Design, Merck Research Laboratories, R80W250, Post Office Box 2000, Rahway, NJ 07065, USA.
4 Centro de Investigación Básica, Merck, Sharp & Dohme de España, S. A. Josefa Valcárcel 38, Madrid 28027, Spain.
5 Department of Cancer Research, Merck Research Laboratories, Post Office Box 4, West Point, PA 19486, USA.
6 Department of Clinical Physiology, Karolinska Hospital, Karolinska Institute, S-171 76 Stockholm, Sweden.
*   To whom correspondence should be addressed. E-mail: bei_zhang{at}merck.com

dagger    Present address: Huffington Center on Aging and Department of Cell Biology, Baylor College of Medicine, One Baylor Plaza, M-320, Houston, TX 77030, USA.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets.
S. E Leney and J. M Tavare (2009)
J. Endocrinol. 203, 1-18
   Abstract »    Full Text »    PDF »
Central Control of Body Weight and Appetite.
S. C. Woods and D. A. D'Alessio (2008)
J. Clin. Endocrinol. Metab. 93, s37-s50
   Abstract »    Full Text »    PDF »
[3H]Org 43553, the First Low-Molecular-Weight Agonistic and Allosteric Radioligand for the Human Luteinizing Hormone Receptor.
L. H. Heitman, J. Oosterom, K. M. Bonger, C. M. Timmers, P. H. G. Wiegerinck, and A. P. IJzerman (2008)
Mol. Pharmacol. 73, 518-524
   Abstract »    Full Text »    PDF »
Identification of Novel Orally Available Small Molecule Insulin Mimetics.
B. Lin, Z. Li, K. Park, L. Deng, A. Pai, L. Zhong, M. C. Pirrung, and N. J. G. Webster (2007)
J. Pharmacol. Exp. Ther. 323, 579-585
   Abstract »    Full Text »    PDF »
Neuroprotection by Small Molecule Activators of the Nerve Growth Factor Receptor.
B. Lin, M. C. Pirrung, L. Deng, Z. Li, Y. Liu, and N. J. G. Webster (2007)
J. Pharmacol. Exp. Ther. 322, 59-69
   Abstract »    Full Text »    PDF »
Treating insulin resistance: future prospects.
C. J Bailey (2007)
Diabetes and Vascular Disease Research 4, 20-31
   Abstract »    PDF »
From the Cover: Small-molecule agonists for the glucagon-like peptide 1 receptor.
L. B. Knudsen, D. Kiel, M. Teng, C. Behrens, D. Bhumralkar, J. T. Kodra, J. J. Holst, C. B. Jeppesen, M. D. Johnson, J. C. de Jong, et al. (2007)
PNAS 104, 937-942
   Abstract »    Full Text »    PDF »
Small, nonpeptide p75NTR ligands induce survival signaling and inhibit proNGF-induced death..
S. M. Massa, Y. Xie, T. Yang, A. W. Harrington, M. L. Kim, S. O. Yoon, R. Kraemer, L. A. Moore, B. L. Hempstead, and F. M. Longo (2006)
J. Neurosci. 26, 5288-5300
   Abstract »    Full Text »    PDF »
Allosteric Activation of the Follicle-stimulating Hormone (FSH) Receptor by Selective, Nonpeptide Agonists.
S. D. Yanofsky, E. S. Shen, F. Holden, E. Whitehorn, B. Aguilar, E. Tate, C. P. Holmes, R. Scheuerman, D. MacLean, M. M. Wu, et al. (2006)
J. Biol. Chem. 281, 13226-13233
   Abstract »    Full Text »    PDF »
Therapeutic Actions of an Insulin Receptor Activator and a Novel Peroxisome Proliferator-Activated Receptor {gamma} Agonist in the Spontaneously Hypertensive Obese Rat Model of Metabolic Syndrome X.
R. A. Velliquette, J. E. Friedman, J. Shao, B. B. Zhang, and P. Ernsberger (2005)
J. Pharmacol. Exp. Ther. 314, 422-430
   Abstract »    Full Text »    PDF »
Small-Molecule Insulin Mimetic Reduces Hyperglycemia and Obesity in a Nongenetic Mouse Model of Type 2 Diabetes.
M. Z. Strowski, Z. Li, D. Szalkowski, X. Shen, X.-M. Guan, S. Juttner, D. E. Moller, and B. B. Zhang (2004)
Endocrinology 145, 5259-5268
   Abstract »    Full Text »    PDF »
Glycemic Treatment: Control of glycemia.
Z. T. Bloomgarden (2004)
Diabetes Care 27, 1227-1234
   Full Text »    PDF »
Bioprospecting for Microbial Endophytes and Their Natural Products.
G. Strobel and B. Daisy (2003)
Microbiol. Mol. Biol. Rev. 67, 491-502
   Abstract »    Full Text »    PDF »
Structural and Biochemical Evidence for an Autoinhibitory Role for Tyrosine 984 in the Juxtamembrane Region of the Insulin Receptor.
S. Li, N. D. Covino, E. G. Stein, J. H. Till, and S. R. Hubbard (2003)
J. Biol. Chem. 278, 26007-26014
   Abstract »    Full Text »    PDF »
Identification of a Compound That Directly Stimulates Phospholipase C Activity.
Y.-S. Bae, T. G. Lee, J. C. Park, J. H. Hur, Y. Kim, K. Heo, J.-Y. Kwak, P.-G. Suh, and S. H. Ryu (2003)
Mol. Pharmacol. 63, 1043-1050
   Abstract »    Full Text »    PDF »
Early Clinical Development of Pharmaceuticals for Type 2 Diabetes Mellitus: From Preclinical Models to Human Investigation.
J. A. Wagner (2002)
J. Clin. Endocrinol. Metab. 87, 5362-5366
   Full Text »    PDF »
Regulation of Insulin Receptor Function by a Small Molecule Insulin Receptor Activator.
C. Pender, I. D. Goldfine, V. P. Manchem, J. L. Evans, W. R. Spevak, S. Shi, S. Rao, S. Bajjalieh, B. A. Maddux, and J. F. Youngren (2002)
J. Biol. Chem. 277, 43565-43571
   Abstract »    Full Text »    PDF »
Decreased Insulin Receptor (IR) Autophosphorylation in Fibroblasts from Patients with PCOS: Effects of Serine Kinase Inhibitors and IR Activators.
M. Li, J. F. Youngren, A. Dunaif, I. D. Goldfine, B. A. Maddux, B. B. Zhang, and J. L. Evans (2002)
J. Clin. Endocrinol. Metab. 87, 4088-4093
   Abstract »    Full Text »    PDF »
Effect of the Insulin Mimetic L-783,281 on Intracellular [Ca2+] and Insulin Secretion From Pancreatic {beta}-Cells.
M. G. Roper, W.-j. Qian, B. B. Zhang, R. N. Kulkarni, C. R. Kahn, and R. T. Kennedy (2002)
Diabetes 51, S43-49
   Abstract »    Full Text »    PDF »
Glucose-Dependent Promotion of Insulin Release From Mouse Pancreatic Islets by the Insulin-Mimetic Compound L-783,281.
J. Westerlund, B. A. Wolf, and P. Bergsten (2002)
Diabetes 51, S50-52
   Abstract »    Full Text »    PDF »
Distinct and Overlapping Functions of Insulin and IGF-I Receptors.
J. Nakae, Y. Kido, and D. Accili (2001)
Endocr. Rev. 22, 818-835
   Abstract »    Full Text »    PDF »
Small Molecule Insulin Receptor Activators Potentiate Insulin Action in Insulin-Resistant Cells.
M. Li, J. F. Youngren, V. P. Manchem, M. Kozlowski, B. B. Zhang, B. A. Maddux, and I. D. Goldfine (2001)
Diabetes 50, 2323-2328
   Abstract »    Full Text »
Functional Genomics and Cardiovascular Drug Discovery.
R. T. Lee (2001)
Circulation 104, 1441-1446
   Full Text »    PDF »
A Hydroxychalcone Derived from Cinnamon Functions as a Mimetic for Insulin in 3T3-L1 Adipocytes.
K. J. Jarvill-Taylor, R. A. Anderson, and D. J. Graves (2001)
J. Am. Coll. Nutr. 20, 327-336
   Abstract »    Full Text »    PDF »
Activation of the Insulin-Like Growth Factor 1 Signaling Pathway by the Antiapoptotic Agents Aurintricarboxylic Acid and Evans Blue.
R. Beery, M. Haimsohn, N. Wertheim, R. Hemi, U. Nir, A. Karasik, H. Kanety, and A. Geier (2001)
Endocrinology 142, 3098-3107
   Abstract »    Full Text »    PDF »
A Novel Small Molecule That Directly Sensitizes the Insulin Receptor In Vitro and In Vivo.
V. P. Manchem, I. D. Goldfine, R. A. Kohanski, C. P. Cristobal, R. T. Lum, S. R. Schow, S. Shi, W. R. Spevak, E. Laborde, D. K. Toavs, et al. (2001)
Diabetes 50, 824-830
   Abstract »    Full Text »
Recent Advances in Our Understanding of Insulin Action and Insulin Resistance.
D. Le Roith and Y. Zick (2001)
Diabetes Care 24, 588-597
   Abstract »    Full Text »
Pathophysiology and Pharmacological Treatment of Insulin Resistance.
S. Matthaei, M. Stumvoll, M. Kellerer, and H.-U. Häring (2000)
Endocr. Rev. 21, 585-618
   Abstract »    Full Text »
Erythropoietin mimetic peptides and the future.
D. L. Johnson and L. K. Jolliffe (2000)
Nephrol. Dial. Transplant. 15, 1274-1277
   Full Text »    PDF »
Mimicking dominant negative inhibition of prion replication through structure-based drug design.
V. Perrier, A. C. Wallace, K. Kaneko, J. Safar, S. B. Prusiner, and F. E. Cohen (2000)
PNAS 97, 6073-6078
   Abstract »    Full Text »    PDF »
Genuine Monovalent Ligands of TrkA Nerve Growth Factor Receptors Reveal a Novel Pharmacological Mechanism of Action.
S. Maliartchouk, T. Debeir, N. Beglova, A. C. Cuello, K. Gehring, and H. U. Saragovi (2000)
J. Biol. Chem. 275, 9946-9956
   Abstract »    Full Text »    PDF »
A Designed Peptidomimetic Agonistic Ligand of TrkA Nerve Growth Factor Receptors.
S. Maliartchouk, Y. Feng, L. Ivanisevic, T. Debeir, A. C. Cuello, K. Burgess, and H. U. Saragovi (2000)
Mol. Pharmacol. 57, 385-391
   Abstract »    Full Text »
A Fungus May Help Create an 'Insulin Pill'.
(1999)
Journal Watch Dermatology 1999, 13
   Full Text »
A Fungus May Help Create an ""Insulin Pill"".
(1999)
Journal Watch (General) 1999, 4
   Full Text »
Activation of Insulin Signal Transduction Pathway and Anti-diabetic Activity of Small Molecule Insulin Receptor Activators.
S. A. Qureshi, V. Ding, Z. Li, D. Szalkowski, D. E. Biazzo-Ashnault, D. Xie, R. Saperstein, E. Brady, S. Huskey, X. Shen, et al. (2000)
J. Biol. Chem. 275, 36590-36595
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)